Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Community Pharmacy Services | 5 | 2020 | 24 | 2.310 |
Why?
|
| Pharmacists | 6 | 2020 | 53 | 2.140 |
Why?
|
| Cyclonic Storms | 4 | 2019 | 62 | 1.940 |
Why?
|
| Puerto Rico | 15 | 2023 | 1352 | 1.220 |
Why?
|
| Platelet Aggregation Inhibitors | 6 | 2021 | 60 | 0.870 |
Why?
|
| Patient Care | 2 | 2019 | 28 | 0.860 |
Why?
|
| Acute Coronary Syndrome | 2 | 2020 | 35 | 0.850 |
Why?
|
| Professional Role | 2 | 2019 | 38 | 0.830 |
Why?
|
| Disaster Planning | 2 | 2018 | 51 | 0.750 |
Why?
|
| Education, Pharmacy | 1 | 2019 | 32 | 0.680 |
Why?
|
| Thrombosis | 1 | 2018 | 61 | 0.650 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 141 | 0.640 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 143 | 0.630 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 221 | 0.570 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 790 | 0.530 |
Why?
|
| Motivation | 1 | 2018 | 415 | 0.520 |
Why?
|
| Opioid-Related Disorders | 3 | 2021 | 112 | 0.510 |
Why?
|
| Dietary Supplements | 1 | 2016 | 196 | 0.500 |
Why?
|
| Cross-Sectional Studies | 7 | 2021 | 2561 | 0.410 |
Why?
|
| Smoking | 1 | 2018 | 903 | 0.410 |
Why?
|
| Humans | 21 | 2023 | 34853 | 0.410 |
Why?
|
| Buprenorphine | 2 | 2021 | 19 | 0.400 |
Why?
|
| Drug Storage | 3 | 2020 | 27 | 0.380 |
Why?
|
| Aryldialkylphosphatase | 3 | 2018 | 9 | 0.380 |
Why?
|
| Ticlopidine | 2 | 2018 | 15 | 0.320 |
Why?
|
| Vaccination | 2 | 2021 | 259 | 0.310 |
Why?
|
| Middle Aged | 7 | 2021 | 9642 | 0.310 |
Why?
|
| Blood Platelets | 2 | 2018 | 74 | 0.300 |
Why?
|
| Pharmacogenetics | 3 | 2021 | 45 | 0.290 |
Why?
|
| Male | 9 | 2021 | 18870 | 0.290 |
Why?
|
| Aged | 6 | 2021 | 6448 | 0.290 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 531 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 638 | 0.250 |
Why?
|
| Narcotic Antagonists | 2 | 2021 | 50 | 0.250 |
Why?
|
| Benzodiazepines | 1 | 2023 | 13 | 0.240 |
Why?
|
| Female | 9 | 2021 | 19873 | 0.240 |
Why?
|
| Genotype | 3 | 2021 | 641 | 0.220 |
Why?
|
| Adult | 5 | 2021 | 11034 | 0.210 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 14 | 0.210 |
Why?
|
| Gene Frequency | 2 | 2018 | 155 | 0.210 |
Why?
|
| Intention | 1 | 2021 | 84 | 0.190 |
Why?
|
| Guaifenesin | 1 | 2020 | 1 | 0.190 |
Why?
|
| Dextromethorphan | 1 | 2020 | 3 | 0.190 |
Why?
|
| Dexamethasone | 1 | 2020 | 43 | 0.190 |
Why?
|
| Drug Compounding | 1 | 2020 | 70 | 0.180 |
Why?
|
| Clinical Competence | 1 | 2020 | 124 | 0.180 |
Why?
|
| Professional Competence | 1 | 2019 | 34 | 0.180 |
Why?
|
| Galactosyltransferases | 1 | 2018 | 6 | 0.170 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 31 | 0.170 |
Why?
|
| Platelet Aggregation | 1 | 2018 | 17 | 0.170 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 171 | 0.170 |
Why?
|
| Stents | 1 | 2018 | 59 | 0.170 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2018 | 46 | 0.170 |
Why?
|
| Telecommunications | 1 | 2018 | 1 | 0.160 |
Why?
|
| Electric Power Supplies | 1 | 2018 | 10 | 0.160 |
Why?
|
| Perception | 1 | 2019 | 183 | 0.160 |
Why?
|
| Tetrazoles | 1 | 2018 | 49 | 0.160 |
Why?
|
| Prescription Drugs | 1 | 2018 | 31 | 0.160 |
Why?
|
| Pharmacies | 1 | 2018 | 19 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2019 | 74 | 0.160 |
Why?
|
| Trust | 1 | 2019 | 119 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 186 | 0.150 |
Why?
|
| Medication Adherence | 1 | 2019 | 165 | 0.150 |
Why?
|
| Drug Resistance | 1 | 2017 | 93 | 0.150 |
Why?
|
| Disasters | 1 | 2018 | 64 | 0.150 |
Why?
|
| Food Supply | 1 | 2018 | 99 | 0.140 |
Why?
|
| Certification | 1 | 2016 | 13 | 0.140 |
Why?
|
| Attitude to Health | 1 | 2019 | 311 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 355 | 0.140 |
Why?
|
| Papillomavirus Vaccines | 1 | 2017 | 136 | 0.130 |
Why?
|
| Young Adult | 3 | 2019 | 4012 | 0.120 |
Why?
|
| Health Education | 1 | 2017 | 304 | 0.120 |
Why?
|
| Neoplasms | 1 | 2023 | 1033 | 0.120 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 176 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 628 | 0.100 |
Why?
|
| Platelet Function Tests | 2 | 2018 | 7 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2020 | 1349 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1353 | 0.060 |
Why?
|
| Naloxone | 1 | 2021 | 50 | 0.050 |
Why?
|
| West Indies | 1 | 2021 | 10 | 0.050 |
Why?
|
| Leadership | 1 | 2021 | 63 | 0.050 |
Why?
|
| Dinucleoside Phosphates | 1 | 2020 | 11 | 0.050 |
Why?
|
| Expectorants | 1 | 2020 | 1 | 0.050 |
Why?
|
| Antitussive Agents | 1 | 2020 | 4 | 0.050 |
Why?
|
| Caribbean Region | 1 | 2020 | 63 | 0.050 |
Why?
|
| Color | 1 | 2020 | 19 | 0.050 |
Why?
|
| Viscosity | 1 | 2020 | 37 | 0.050 |
Why?
|
| Drug Stability | 1 | 2020 | 110 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2020 | 80 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2020 | 212 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 375 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 342 | 0.040 |
Why?
|
| Psychometrics | 1 | 2020 | 292 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2018 | 26 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 118 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2018 | 171 | 0.040 |
Why?
|
| Educational Status | 1 | 2019 | 295 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 188 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 217 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 435 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 213 | 0.040 |
Why?
|
| Linear Models | 1 | 2017 | 253 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 424 | 0.040 |
Why?
|
| Parents | 1 | 2019 | 288 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1007 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 517 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 570 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 628 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 1681 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 871 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 1318 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 894 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 727 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 1003 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2333 | 0.020 |
Why?
|
| United States | 1 | 2020 | 3894 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 3414 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 5035 | 0.020 |
Why?
|